Dr. Rajiv I. ModiChairman and Managing Director of Cadila Pharmaceuticals Ltd.
Dr. Rajiv Modi, is a Ph.D. in Biological Science from the University of Michigan, An Arbor, USA, M.Sc. in Biochemical Engineering from University College, London and B. Tech. in Chemical Engineering from Indian Institute of Technology (IIT), Bombay, India. He is the Chairman and Managing Director of Cadila Pharmaceuticals Ltd. and Director on the Board of other Cadila Group companies and has a rich experience of more than 20 years of managing pharmaceutical companies. He has been elected as Fellow of National Academy of Engineering (FNAE), New Delhi.
Mr. Stanley C. ErckPresident and CEO - Novavax Inc.
Mr. Stanley C. Erck is the President and CEO of Novavax Inc., a U.S. based clinical-stage vaccine company, since February, 2010. Mr. Erck also sits on the Board of Directors of MacCyte and MdBio Foundation.
Dr. James F. YoungChairman â€“ Novavax Inc.
Dr. James F. Young has over 30 years of experience in the fields of molecular genetics, microbiology, immunology and pharmaceutical development. He was previously the President of Research and Development, also responsible for regulatory affairs, at MedImmune.
Mr. Ramesh R. Choksi
Mr. Ramesh R. Choksi is M.Com (Honors) and Fellow Member of Institute of Chartered Accountants of India. He brings with him 42 years of vast experience in the areas of Finance, Accounts, Taxation, MIS, general management, project management (green field).